Glaxosmithkline



Ebit Veränderung Datum
AbbVie USD 5.24B 1.5B 2024-12
Amgen USD 4.03B 11M 2024-12
AstraZeneca USD 4.8B 604M 2025-03
Aurora Cannabis CAD 36.86M 39.25M 2024-12
Bausch Health Companies USD 546M 315M 2024-12
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Canopy Growth CAD -23822000 22.12M 2024-12
Corcept Therapeutics USD 25.26M 20.34M 2024-12
Drreddys Laboratories INR 18.02B 1.22B 2024-12
Eli Lilly USD 5.63B 3.88B 2024-12
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Indivior 101M 92M 2024-12
J&J USD 7.39B 2.04B 2025-03
Merck USD 5.22B 339M 2024-12
Novartis USD 4.86B 286M 2024-12
Pacira USD 56.14M 7.23M 2024-12
Perrigo USD 193.9M 11.5M 2024-12
Pfizer USD 5.93B 1.31B 2025-03
Prestige Brands USD 91.96M 7.62M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.9B 824M 2025-03
Supernus Pharmaceuticals USD 48.3M 19.4M 2024-12
Takeda JPY 58B 129.82B 2024-12
Teva Pharmaceutical Industries USD 1.17B 100M 2024-12
Zoetis USD 988M 30M 2024-12



Glaxosmithkline - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.